JP2007512842A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007512842A5 JP2007512842A5 JP2006542692A JP2006542692A JP2007512842A5 JP 2007512842 A5 JP2007512842 A5 JP 2007512842A5 JP 2006542692 A JP2006542692 A JP 2006542692A JP 2006542692 A JP2006542692 A JP 2006542692A JP 2007512842 A5 JP2007512842 A5 JP 2007512842A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- construct
- virus
- peptide
- icosahedral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 25
- 108090000765 processed proteins & peptides Proteins 0.000 claims 25
- 210000000234 capsid Anatomy 0.000 claims 14
- 150000007523 nucleic acids Chemical class 0.000 claims 13
- 241000700605 Viruses Species 0.000 claims 12
- 230000004927 fusion Effects 0.000 claims 8
- 108020004707 nucleic acids Proteins 0.000 claims 7
- 102000039446 nucleic acids Human genes 0.000 claims 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 6
- 239000002245 particle Substances 0.000 claims 6
- 241000589516 Pseudomonas Species 0.000 claims 5
- 239000000427 antigen Substances 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 231100000331 toxic Toxicity 0.000 claims 3
- 230000002588 toxic effect Effects 0.000 claims 3
- 230000003612 virological effect Effects 0.000 claims 3
- 241000724328 Alfalfa mosaic virus Species 0.000 claims 2
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims 2
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims 2
- 241000724254 Cowpea chlorotic mottle virus Species 0.000 claims 2
- 241000723655 Cowpea mosaic virus Species 0.000 claims 2
- 241000196324 Embryophyta Species 0.000 claims 2
- 239000000178 monomer Substances 0.000 claims 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims 2
- 241000701931 Canine parvovirus Species 0.000 claims 1
- 108091028732 Concatemer Proteins 0.000 claims 1
- 241000710945 Eastern equine encephalitis virus Species 0.000 claims 1
- 241000589540 Pseudomonas fluorescens Species 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 229960002235 anthrax antigen Drugs 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52598203P | 2003-12-01 | 2003-12-01 | |
| PCT/US2004/040117 WO2005067478A2 (en) | 2003-12-01 | 2004-12-01 | Recombinant icosahedral virus like particle production in pseudomonads |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007512842A JP2007512842A (ja) | 2007-05-24 |
| JP2007512842A5 true JP2007512842A5 (enExample) | 2008-01-17 |
Family
ID=34794205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006542692A Pending JP2007512842A (ja) | 2003-12-01 | 2004-12-01 | シュードモナスにおける組換え二十面体ウイルス様粒子の生産 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050214321A1 (enExample) |
| EP (1) | EP1758925A4 (enExample) |
| JP (1) | JP2007512842A (enExample) |
| KR (1) | KR20060114340A (enExample) |
| CN (1) | CN101151272A (enExample) |
| AU (1) | AU2004313458B2 (enExample) |
| BR (1) | BRPI0417159A (enExample) |
| CA (1) | CA2547511A1 (enExample) |
| MX (1) | MXPA06006221A (enExample) |
| WO (1) | WO2005067478A2 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9453251B2 (en) | 2002-10-08 | 2016-09-27 | Pfenex Inc. | Expression of mammalian proteins in Pseudomonas fluorescens |
| CA2547511A1 (en) * | 2003-12-01 | 2005-07-28 | Dow Global Technolgies Inc. | Recombinant icosahedral virus like particle production in pseudomonads |
| US7928290B2 (en) * | 2004-02-27 | 2011-04-19 | Dow Agrosciences Llc | Viral capsid fusion peptide expressing plant cells |
| BRPI0513826A2 (pt) | 2004-07-26 | 2010-06-22 | Dow Global Technologies Inc | processo para expressão de proteìna melhorada através de engenharia de cepa |
| BRPI0611336A2 (pt) * | 2005-06-01 | 2010-08-31 | Dow Global Technologies Inc | método para produzir uma partìcula multivalente semelhante a vìrus, partìcula multivalente semelhante a vìrus, método de aumentar a solubilidade de uma partìcula multivalente semelhante a vìrus e vacina |
| CA2615658A1 (en) * | 2005-07-19 | 2007-01-25 | Dow Global Technolgies Inc. | Recombinant flu vaccines |
| WO2008027099A2 (en) * | 2006-05-30 | 2008-03-06 | Dow Global Technologies Inc. | Rpa optimization |
| AT503690A1 (de) * | 2006-06-09 | 2007-12-15 | Biomay Ag | Hypoallergene moleküle |
| US7998487B2 (en) * | 2007-02-16 | 2011-08-16 | The Salk Institute For Biological Studies | Antitoxin and vaccine platform based on nodavirus VLPs |
| US9580719B2 (en) | 2007-04-27 | 2017-02-28 | Pfenex, Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| US9394571B2 (en) | 2007-04-27 | 2016-07-19 | Pfenex Inc. | Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins |
| EP2371840B1 (en) | 2008-11-28 | 2014-04-16 | AnGes MG, Inc. | Novel polypeptide having angiogenesis-inducing activity and antibacterial activity, and use thereof for medical purposes |
| JP5750765B2 (ja) * | 2009-03-06 | 2015-07-22 | 株式会社ファンペップ | ポリペプチド及びその抗菌または消毒用途 |
| WO2010137594A1 (ja) | 2009-05-25 | 2010-12-02 | アンジェスＭｇ株式会社 | 血管新生誘導活性及び抗菌活性を有するポリペプチドおよびそれを含有する創傷治療剤 |
| IN2012DN00324A (enExample) * | 2009-06-15 | 2015-05-08 | Plant Bioscience Ltd | |
| KR102181258B1 (ko) | 2012-02-16 | 2020-11-20 | 브이엘피 테라퓨틱스 엘엘씨 | 바이러스 유사 입자 조성물 |
| RU2525136C1 (ru) * | 2012-12-14 | 2014-08-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Способ получения препаративных количеств антигенов флоэмно-ограниченных вирусов |
| RU2555534C2 (ru) * | 2013-05-23 | 2015-07-10 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Способ получения препаративных количеств вирусных частиц флоэмно-органиченных вирусов |
| TWI676636B (zh) * | 2013-07-12 | 2019-11-11 | Ｖｌｐ醫療股份有限公司 | 包含ｐｄ－１抗原或ｐｄ－１配體抗原的類病毒粒子 |
| CN103409377B (zh) * | 2013-08-28 | 2015-12-23 | 中国农业科学院兰州兽医研究所 | 犬细小病毒病毒样颗粒的制备及用途 |
| CN103882047B (zh) * | 2014-03-18 | 2016-06-29 | 杨霞 | 重组人酸性成纤维细胞生长因子蛋白的制备方法 |
| US10385101B2 (en) | 2014-08-08 | 2019-08-20 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
| US9969986B2 (en) | 2014-08-08 | 2018-05-15 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
| KR102532832B1 (ko) | 2014-09-11 | 2023-05-16 | 브이엘피 테라퓨틱스 인코포레이티드 | 플라비바이러스 바이러스 유사 입자 |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| SG11202005792RA (en) | 2017-12-20 | 2020-07-29 | Vlp Therapeutics Llc | Alphavirus replicon particle |
| TWI891771B (zh) | 2020-04-17 | 2025-08-01 | 美商Ｖｌｐ醫療股份有限公司 | 冠狀病毒疫苗 |
| AU2021264216A1 (en) | 2020-04-30 | 2022-11-10 | Vlp Therapeutics, Inc. | Cytokine immunotherapy |
| CN113278622B (zh) * | 2021-06-09 | 2023-09-19 | 集美大学 | 一种变形假单胞菌适配体及其筛选方法 |
| WO2024006433A1 (en) * | 2022-06-30 | 2024-01-04 | Carnegie Mellon University | Method for production of virus-like particles for gene delivery |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4595658A (en) * | 1982-09-13 | 1986-06-17 | The Rockefeller University | Method for facilitating externalization of proteins synthesized in bacteria |
| US4511503A (en) * | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| US4755465A (en) * | 1983-04-25 | 1988-07-05 | Genentech, Inc. | Secretion of correctly processed human growth hormone in E. coli and Pseudomonas |
| US4680264A (en) * | 1983-07-01 | 1987-07-14 | Lubrizol Genetics, Inc. | Class II mobilizable gram-negative plasmid |
| US5281532A (en) * | 1983-07-27 | 1994-01-25 | Mycogen Corporation | Pseudomas hosts transformed with bacillus endotoxin genes |
| US4637980A (en) * | 1983-08-09 | 1987-01-20 | Smithkline Beckman Corporation | Externalization of products of bacteria |
| US4695462A (en) * | 1985-06-28 | 1987-09-22 | Mycogen Corporation | Cellular encapsulation of biological pesticides |
| US4695455A (en) * | 1985-01-22 | 1987-09-22 | Mycogen Corporation | Cellular encapsulation of pesticides produced by expression of heterologous genes |
| US5232840A (en) * | 1986-03-27 | 1993-08-03 | Monsanto Company | Enhanced protein production in bacteria by employing a novel ribosome binding site |
| US5128130A (en) * | 1988-01-22 | 1992-07-07 | Mycogen Corporation | Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens |
| US5316931A (en) * | 1988-02-26 | 1994-05-31 | Biosource Genetics Corp. | Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes |
| US6054566A (en) * | 1988-02-26 | 2000-04-25 | Biosource Technologies, Inc. | Recombinant animal viral nucleic acids |
| US5055294A (en) * | 1988-03-03 | 1991-10-08 | Mycogen Corporation | Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens |
| US5169772A (en) * | 1988-06-06 | 1992-12-08 | Massachusetts Institute Of Technology | Large scale method for purification of high purity heparinase from flavobacterium heparinum |
| US6780613B1 (en) * | 1988-10-28 | 2004-08-24 | Genentech, Inc. | Growth hormone variants |
| US5169760A (en) * | 1989-07-27 | 1992-12-08 | Mycogen Corporation | Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters |
| GB9108386D0 (en) * | 1991-04-19 | 1991-06-05 | Agricultural Genetics Co | Modified plant viruses as vectors |
| US5527883A (en) * | 1994-05-06 | 1996-06-18 | Mycogen Corporation | Delta-endotoxin expression in pseudomonas fluorescens |
| CA2202761A1 (en) * | 1994-10-18 | 1996-04-25 | Sean Nicholas Chapman | Method of producing a chimeric protein |
| US5869287A (en) * | 1996-07-12 | 1999-02-09 | Wisconsin Alumni Research Foundation | Method of producing particles containing nucleic acid sequences in yeast |
| KR100312456B1 (ko) * | 1999-03-13 | 2001-11-03 | 윤덕용 | 슈도모나스 플루오레슨스 유래의 외래단백질 분비촉진유전자 |
| US6514948B1 (en) * | 1999-07-02 | 2003-02-04 | The Regents Of The University Of California | Method for enhancing an immune response |
| DE60234375D1 (de) * | 2001-09-14 | 2009-12-24 | Cytos Biotechnology Ag | VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG |
| CA2482995C (en) * | 2002-04-22 | 2013-01-29 | Dow Global Technologies Inc. | Low-cost production of peptides |
| JP2006507800A (ja) * | 2002-06-07 | 2006-03-09 | ラージ・スケール・バイオロジー・コーポレイション | 可撓性ワクチンアセンブリおよびワクチン送達プラットフォーム |
| CA2547511A1 (en) * | 2003-12-01 | 2005-07-28 | Dow Global Technolgies Inc. | Recombinant icosahedral virus like particle production in pseudomonads |
-
2004
- 2004-12-01 CA CA002547511A patent/CA2547511A1/en not_active Abandoned
- 2004-12-01 KR KR1020067010713A patent/KR20060114340A/ko not_active Ceased
- 2004-12-01 US US11/001,626 patent/US20050214321A1/en not_active Abandoned
- 2004-12-01 JP JP2006542692A patent/JP2007512842A/ja active Pending
- 2004-12-01 WO PCT/US2004/040117 patent/WO2005067478A2/en not_active Ceased
- 2004-12-01 BR BRPI0417159-4A patent/BRPI0417159A/pt not_active IP Right Cessation
- 2004-12-01 MX MXPA06006221A patent/MXPA06006221A/es unknown
- 2004-12-01 EP EP04821151A patent/EP1758925A4/en not_active Withdrawn
- 2004-12-01 CN CNA2004800410956A patent/CN101151272A/zh active Pending
- 2004-12-01 AU AU2004313458A patent/AU2004313458B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007512842A5 (enExample) | ||
| López-Sagaseta et al. | Self-assembling protein nanoparticles in the design of vaccines | |
| Bao et al. | Phage-based vaccines | |
| US10894079B2 (en) | Chromatography based purification strategies for viruses | |
| Marsian et al. | Molecular pharming—VLPs made in plants | |
| Takahashi et al. | p26 protein and 33-nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts | |
| Kalnciema et al. | Potato virus Y-like particles as a new carrier for the presentation of foreign protein stretches | |
| WO2005067478A3 (en) | Recombinant icosahedral virus like particle production in pseudomonads | |
| JP2013517773A5 (enExample) | ||
| JP2005514333A5 (enExample) | ||
| CN1972710B (zh) | 包含噬菌体纳米颗粒的方法和组合物 | |
| JP2025169275A5 (enExample) | ||
| JP2010508857A5 (enExample) | ||
| JP2010538619A5 (enExample) | ||
| Sun et al. | Toward innovative veterinary nanoparticle vaccines | |
| Chen et al. | Determinants of rotavirus stability and density during CsCl purification | |
| CA2461579A1 (en) | Porcine adenovirus e1 region | |
| Jha et al. | Self-assembling of coiled-coil peptides into virus-like particles: Basic principles, properties, design, and applications with special focus on vaccine design and delivery | |
| Sharma et al. | Virus-like particles for disease diagnosis and drug delivery applications | |
| CN104531741B (zh) | 增强hpv抗原表位肽免疫原性的方法及类病毒颗粒、颗粒制备方法与应用 | |
| CN101278043A (zh) | 获自传染性法氏囊病病毒（ibdv）的嵌合空心病毒样颗粒，其制备方法和应用 | |
| CN111996203A (zh) | 重组o型口蹄疫病毒表位基因的塞内卡重组病毒、重组疫苗及其制备方法和应用 | |
| CN119350457B (zh) | 一种脊髓灰质炎疫苗及其制备方法 | |
| Allam et al. | Perspective vaccines for emerging viral diseases in farm animals | |
| CN102464721B (zh) | 针对人肠道病毒71型的重组广谱性疫苗 |